跳至主要内容
临床试验/NCT04350255
NCT04350255招募中不适用

STEISURE - Trident II - A Registerbased Multicentric Prospective Study

Sahlgrenska University Hospital, Sweden2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
2
主要终点
Implant survival at 3 years

研究概览

简要总结

In a prospective register-based study, we aim to evaluate the implant survival, clinical outcomes and X-ray findings by following a cohort of patients operated with the Trident II cup.

详细描述

Data will be collected from a cohort consisting of minimum 500 total hip arthroplasties. The patients will be recruited from multiple high volume centers in Sweden. To determine if there is evidence of inferiority as per benchmarking recommendations by The Orthopaedic Data Evaluation Panel the following parameters will be studied: Clinical parameters such as EQ-5D, Oxford Hip Score and Forgotten Joint Score, preoperative and after 1, 3, 6 and 10 years. Conventional radiography will be done preoperatively, postoperatively, 3, 6 and 10 years after total hip replacement. CTMA will be done postoperatively, 3 and 6 month and 2 years after total hip replacement.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary hip replacement
  • Eligible for uncemented fixation of the acetabular component
  • Suitable for one of the stem designs from Stryker Orthopaedics
  • Accepts follow-up according to the study protocol

排除标准

  • Difficulties to understand written information due to language problems or other reasons
  • Use of augments needed
  • Acute hip fracture
  • Tumor in the hip joint

结局指标

主要结局

Implant survival at 3 years

时间窗: 3 years

Kaplan Meier survival data, cup revision and risk of revision used as endpoints

次要结局

  • EQ-5D(10 years)
  • Adverse events using the regional VEGA database(10 years)
  • Implant migration measured with Computer Tomography Microanalysis in a subcohort of patients motion Analysis (CTMA) in a sub-cohort of patients(CTMA will be done postoperatively, 3 month and 6 months and 2 years after total hip replacement)
  • Plain radiographs in a sub-cohort of patients(10 years)
  • Implant survival at 10 years(10 years)
  • Adverse events using the national patient register(10 years)
  • Oxford Hip Score(10 years)
  • Forgotten Joint Score(10 years)

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maziar Mohaddes Ardebili

Sahlgrenska University Hospital, Sweden

Sahlgrenska University Hospital, Sweden

研究点 (2)

Loading locations...

相似试验